Highlights in gastro-intestinal cancer
Source
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Intersectionality between country, gender and funding in authorship for phase III trials presented at the ASCO Annual Meeting 2022
Source
JCO global oncology - ISSN 2687-8941-10 (2024) p. 1-9
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer : an AGEO real-world multicenter study
Source
ESMO Open - ISSN 2059-7029-9:9 (2024) p. 1-11
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1) : a single-arm, multicentre, phase 1b/2 study
Source
The lancet oncology - ISSN 1470-2045-25:7 (2024) p. 853-864
Phase II study to determine the antitumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer
Source
Clinical cancer research - ISSN 1078-0432-30:14 (2024) p. 2945-2953